Related Experiment Videos
Acute myelogenous leukemia with eosinophilic differentiation and trisomy-1
D S Harrington1, C Peterson, M Ness
1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68105.
American Journal of Clinical Pathology
|October 1, 1988
Summary
A rare case of acute myelogenous leukemia with eosinophilic differentiation and trisomy-1 was observed. This genetic abnormality in leukemia with eosinophilic features is a novel finding, presenting unique diagnostic and therapeutic challenges.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute myelogenous leukemia (AML) is a heterogeneous clonal hematopoietic stem cell disorder.
- Eosinophilic differentiation in AML, while recognized, is less common and can present with distinct clinical and pathological features.
- Chromosomal abnormalities are frequently observed in AML and play a crucial role in prognosis and classification.
Observation:
- A 50-year-old woman presented with anemia and marked eosinophilia.
- Bone marrow biopsy and peripheral blood analysis revealed features consistent with evolving acute myelogenous leukemia.
- Striking dysplastic eosinophilic differentiation was noted, alongside the presence of trisomy-1 and eosinophil granule major basic protein.
Findings:
- This case represents the first reported instance of acute myelogenous leukemia with eosinophilic differentiation associated with trisomy-1.
- The presence of trisomy-1 in this context is a novel cytogenetic finding.
- Intensive chemotherapy resulted in a transient clinical and cytogenetic remission.
Implications:
- The association of trisomy-1 with eosinophilic AML expands the cytogenetic landscape of this disease.
- This finding may necessitate re-evaluation of diagnostic criteria and prognostic markers in AML with eosinophilic features.
- Further research is warranted to understand the biological significance and therapeutic implications of trisomy-1 in AML.